Literature DB >> 32714516

State of the Hepatitis C Virus Care Cascade.

David L Thomas1.   

Abstract

Watch the interview with the author.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID： 32714516      PMCID： PMC7373772          DOI： 10.1002/cld.915

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  10 in total

Review 1.  Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.

Authors:  Megan G Hofmeister; Elizabeth M Rosenthal; Laurie K Barker; Eli S Rosenberg; Meredith A Barranco; Eric W Hall; Brian R Edlin; Jonathan Mermin; John W Ward; A Blythe Ryerson
Journal:  Hepatology       Date:  2018-11-06       Impact factor: 17.425

Review 2.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

3.  Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey.

Authors:  Hyun-Seok Kim; Ju Dong Yang; Hashem B El-Serag; Fasiha Kanwal
Journal:  J Viral Hepat       Date:  2019-03-13       Impact factor: 3.728

Review 4.  Global Elimination of Chronic Hepatitis.

Authors:  David L Thomas
Journal:  N Engl J Med       Date:  2019-05-23       Impact factor: 91.245

5.  The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States.

Authors:  Jagpreet Chhatwal; Qiushi Chen; Emily D Bethea; Chin Hur; Anne C Spaulding; Fasiha Kanwal
Journal:  Aliment Pharmacol Ther       Date:  2019-05-22       Impact factor: 8.171

6.  The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries.

Authors:  Andrew M Hill; Sanjay Nath; Bryony Simmons
Journal:  J Virus Erad       Date:  2017-07-01

7.  Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan.

Authors:  Jagpreet Chhatwal; Qiushi Chen; Xiaojie Wang; Turgay Ayer; Yueran Zhuo; Naveed Z Janjua; Fasiha Kanwal
Journal:  JAMA Netw Open       Date:  2019-05-03

8.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

9.  Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016.

Authors:  Eli S Rosenberg; Elizabeth M Rosenthal; Eric W Hall; Laurie Barker; Megan G Hofmeister; Patrick S Sullivan; Patricia Dietz; Jonathan Mermin; A Blythe Ryerson
Journal:  JAMA Netw Open       Date:  2018-12-07

10.  Characterization of the hepatitis C virus epidemic in Pakistan.

Authors:  Sarwat Mahmud; Zaina Al Kanaani; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2019-09-14       Impact factor: 3.090
  10 in total
  6 in total

1.  A cascade of care for alcohol use disorder: Using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care.

Authors:  Carrie M Mintz; Sarah M Hartz; Sherri L Fisher; Alex T Ramsey; Elvin H Geng; Richard A Grucza; Laura J Bierut
Journal:  Alcohol Clin Exp Res       Date:  2021-05-16       Impact factor: 3.928

2.  Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019.

Authors:  Nancy Reau; Mark S Sulkowski; Emmanuel Thomas; Vinay Sundaram; Qingqing Xu; Wei-Han Cheng; Steven E Marx; Oscar A Hayes; Shivaji R Manthena; Viktor Chirikov; Douglas E Dylla; Hannah Brooks; Jana M Carabino; Sammy Saab
Journal:  Adv Ther       Date:  2021-10-27       Impact factor: 3.845

3.  Usability and acceptability of oral fluid hepatitis C self-testing among people who inject drugs in Coastal Kenya: a cross-sectional pilot study.

Authors:  Elena Ivanova Reipold; Emmanuel Fajardo; Emily Juma; David Bukusi; Elkin Bermudez Aza; Muhammad S Jamil; Cheryl Case Johnson; Carey Farquhar; Philippa Easterbrook; Aliza Monroe-Wise
Journal:  BMC Infect Dis       Date:  2022-09-15       Impact factor: 3.667

4.  Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV.

Authors:  Ghada E Hegazy; Marwa M Abu-Serie; G M Abou-Elela; Hanan Ghozlan; Soraya A Sabry; Nadia A Soliman; Mohamed Teleb; Yasser R Abdel-Fattah
Journal:  Sci Rep       Date:  2022-10-04       Impact factor: 4.996

5.  Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020.

Authors:  Melissa Perkins; Amber Slevin; Mark A Strand; Daniel Freisner
Journal:  Prev Chronic Dis       Date:  2021-07-15       Impact factor: 2.830

6.  Micro-Elimination of Hepatitis C among Patients with Kidney Disease by Using Electronic Reminder System-A Hospital-Based Experience.

Authors:  Pei-Yuan Su; Wei-Wen Su; Yu-Chun Hsu; Shu-Yi Wang; Ping-Fang Chiu; Hsu-Heng Yen
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.